Skip to content

PAS in Subacute SCI

Paired Associative Stimulation in Subacute Spinal Cord Injury

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04101916
Enrollment
18
Registered
2019-09-24
Start date
2019-10-10
Completion date
2025-01-13
Last updated
2025-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries, Spinal Cord Diseases

Brief summary

The investigators have recently shown in incomplete SCI patients that long-term paired associative stimulation is capable of restoring voluntary control over some paralyzed muscles and enhancing motor output in the weak muscles. In this study, the investigators will administer long-term paired associative stimulation to patients with incomplete cervical level SCI at the subacute stage, and investigate its effectiveness for upper extremity rehabilitation.

Interventions

Paired associative stimulation (PAS) administered several times per week for 12 weeks to upper limbs. PAS comprises transcranial magnetic stimulation (eXimia magnetic stimulator, Nexstim Ltd, Helsinki, Finland) and peripheral nerve stimulation (given with Dantec Keypoint® electroneuromyography device (Natus Medical Incorporated, Pleasanton, CA, USA)).

Sham transcranial magnetic stimulation and sham peripheral nerve stimulation.

Sponsors

Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

The aim is 20 participants and the anticipated dropout percentage is 20%, therefore maximum number of randomized patients will be 24. If there will be no dropouts, only 20 patients will be recruited.

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. SCI caused by an external trauma or SCI caused by nontraumatic non-progressive disease of the spinal cord 2. Cervical level injury, tetraplegia 3. Time from injury/onset of symptoms 1-4 months 4. Medical condition stable 5. Residual neural connectivity in upper extremity: some voluntary activity in finger muscles or MEPs obtainable from distal hand muscles

Exclusion criteria

1. Diagnosed brain damage, visible in MRI or CT. 2. No activity in hands/fingers and no MEPs recorded from distal hand muscles. 3. Epilepsy 4. Metal inclusion in the head area 5. High intracranial pressure 6. Pacemaker 7. Implanted hearing device 8. Progressive diseases of spinal cord or brain (e.g. malignant tumors, degenerative diseases). 9. History of malignant tumor within the past 5 years. 10. Previous head or spinal cord injury affecting the motor performance of upper extremities. 11. Congenital anomaly in the anatomical structure of spinal canal/cord or dura. 12. Significant systemic disease or other condition that could cause neurological deficit, or may affect subject's capability to undergo investigation-related procedures. 13. Acute severe infection. 14. Contraindications for MRI. 15. Current severe psychiatric diseases. 16. Current chronic drug and/or alcohol abuse. 17. Pregnancy. 18. Severe emergency care polyneuropathy 19. Pressure ulcer affecting the subject's capability to undergo the procedure safely

Design outcomes

Primary

MeasureTime frameDescription
Daniels and Worthingham's Muscle TestingChange from baseline score immediately after, 6 months after and 1 year after last stimulation sessionhand muscle strength is evaluated on 0-5 scale (0=no movement, 5=normal)
Spinal Cord Independence Measure (SCIM)Change from baseline score immediately after, 6 months after and 1 year after last stimulation sessionstandard SCIM evaluation

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026